KalVista Pharmaceuticals (KALV) Share-based Compensation Growth (1y) (2015 - 2025)
KalVista Pharmaceuticals (KALV) Share-based Compensation Growth (1y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 118.32% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -40.86% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.18% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5,886.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn | -76.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -76.15% |
| Apr 30, 2025 | -460.18% |
| Oct 31, 2024 | -186.47% |
| Jul 31, 2024 | -6.58% |
| Apr 30, 2024 | -9.87% |
| Jan 31, 2024 | -56.89% |
| Jul 31, 2023 | 172.99% |
| Apr 30, 2023 | 146.52% |
| Jan 31, 2023 | 126.47% |
| Jul 31, 2022 | -57.35% |
| Apr 30, 2022 | -573.98% |
| Jan 31, 2022 | 123.77% |
| Oct 31, 2021 | 129.17% |
| Jul 31, 2021 | 135.27% |
| Apr 30, 2021 | 1.56% |
| Jan 31, 2021 | 10.61% |
| Oct 31, 2020 | 7.40% |
| Jul 31, 2020 | 10.61% |
| Apr 30, 2020 | 28.84% |
| Jan 31, 2020 | 40.78% |